Advertisement
Essay

Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?

  • Suerie Moon mail,

    smoon@hsph.harvard.edu

    Affiliations: Forum on Global Governance for Health, Harvard Global Health Institute, Cambridge, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Jorge Bermudez,

    Affiliation: Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

    X
  • Ellen 't Hoen

    Affiliation: IS Academy HIV/AIDS, School for Social Science Research, University of Amsterdam, The Netherlands

    X
  • Published: May 15, 2012
  • DOI: 10.1371/journal.pmed.1001218
  • Published in PLOS Medicine

About the Authors

Suerie Moon
Forum on Global Governance for Health, Harvard Global Health Institute, Cambridge, Massachusetts, United States of America
Suerie Moon
Harvard School of Public Health, Boston, Massachusetts, United States of America
Jorge Bermudez
Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
Ellen 't Hoen
IS Academy HIV/AIDS, School for Social Science Research, University of Amsterdam, The Netherlands

Corresponding Author

Email: smoon@hsph.harvard.edu

Competing Interests

SM is a member of the Board of Directors of Medecins Sans Frontieres (MSF)/Doctors Without Borders-USA and the Drugs for Neglected Diseases initiative-North America. ETH was the executive director of the Medicines Patent Pool from November 2010 until 1 May 2012. SM has been a consultant to the Medicines Patent Pool. All other authors have declared that no competing interests exist.

Author Contributions

manuscript: SM. Contributed to the writing of the manuscript: SM ETH JB. ICMJE criteria for authorship read and met: SM ETH JB. Agree with manuscript results and conclusions: SM ETH JB.